1. Medtech Insight
  2. >>Policy & Regulation

Expanding Device Eligibility And Other Suggestions For CMS’s TCET Pathway

 
• By Hannah Daniel

Comments submitted by industry members about CMS’s TCET notice highlight the need for greater device eligibility and transparency for the pathway.  

stethescope, calulator, and money on top of helath insurance form
• Source: Shutterstock

In comments submitted to the US Center for Medicare and Medicaid Services, industry members asked for greater transparency and eligibility for the office’s Transitional Coverage for Emerging Technologies (TCET) pathway.

In June, CMS put out a notice with a comment period for the TCET pathway and asked for industry members

Key Takeaways

CMS should…

  • Expand device eligibility for TCET;

  • Increase transparency for program acceptances and rejections;

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.